Compounds > perospirone
Page last updated: 2024-09-03

perospirone and Neuroleptic Malignant Syndrome

perospirone has been researched along with Neuroleptic Malignant Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirayasu, Y; Kato, D; Kawanishi, C; Kishida, I; Matsumura, T; Nakagawa, M; Tamura, K1
Fujita, K; Okazaki, Y; Tanii, H1

Other Studies

2 other study(ies) available for perospirone and Neuroleptic Malignant Syndrome

ArticleYear
Neuroleptic malignant syndrome induced by perospirone.
    The international journal of neuropsychopharmacology, 2006, Volume: 9, Issue:5

    Topics: Antipsychotic Agents; Female; Humans; Indoles; Isoindoles; Middle Aged; Neuroleptic Malignant Syndrome; Thiazoles

2006
Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    The American journal of psychiatry, 2006, Volume: 163, Issue:3

    Topics: Adult; Antipsychotic Agents; Cholinergic Antagonists; Drug Therapy, Combination; Humans; Indoles; Isoindoles; Male; Neuroleptic Malignant Syndrome; Schizophrenia, Paranoid; Substance Withdrawal Syndrome; Thiazoles

2006